Description: SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona.
Home Page: www.senestech.com
SNES Technical Analysis
23460 North 19th Avenue
Phoenix,
AZ
85027
United States
Phone:
928 779 4143
Officers
| Name | Title |
|---|---|
| Mr. Thomas C. Chesterman M.B.A. | Exec. VP, CFO, Treasurer & Assistant Sec. |
| Dr. Steven C. Krause Ph.D. | Exec. VP of Sales & Marketing |
| Mr. Kenneth S. Siegel | Exec. Director |
| Mr. Joel Fruendt | CEO & Director |
| Ms. Kim Patrice Wolin | Exec. VP of Operations & Sec. |
| Ms. Nicole Williams | Chief Strategy Officer |
| Mr. Paul M. Palz | VP & Corp. Controller |
| Robert Blum | Investor Relations |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6001 |
| Price-to-Sales TTM: | 2.1313 |
| IPO Date: | 2016-12-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 26 |